Merck to price bond amid CEO exit

Thursday 24 November 2005 at 16:00

Merck, the German pharmaceuticals company, has forged ahead with the sale of a €500m ($590m) bond despite the departure of its chief executive.

The company said on Tuesday evening that chief executive Bernard Scheuble had been replaced by board member Michael Roemer.